The epidermal growth factor receptor (EGFR)-mutant-lung cancer represents 10% and 25% of non-small-cell lung cancers (NSCLC) in Caucasians and East Asians, respectively [2]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.